A contrarian view and one not outside the realms of possibility, is that big players knew in advance of the drugs pending approval and sold down shares on the news to scare the retail market into offloading so they could pick up at a significant discount. That's the conspiracy theorist in me purely surmising
https://www.biopharmadive.com/news/billy-dunn-fda-depart-agency-neuroscience-alzheimers/643627/
FDA, page-3
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.71 |
Change
0.000(0.00%) |
Mkt cap ! $2.644B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 350 | $30.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.68 | 45 | 1 |
View Market Depth
| Last trade - 16.16pm 24/05/2024 (20 minute delay) ? |
| NEU (ASX) Chart |
Day chart unavailable